Valvular heart disease is characterized by damage to or a defect in one of the four heart valves namely the mitral valve, aortic valve, tricuspid valve, and pulmonary valve.

The global Valvular Heart Disease Treatment market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Valvular Heart Disease Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Valvular Heart Disease Treatment.

Report Scope

The Valvular Heart Disease Treatment market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Valvular Heart Disease Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Valvular Heart Disease Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Valvular Heart Disease Treatment Market Report

Report Metric	Details
Report Name	Valvular Heart Disease Treatment Market
CAGR	5%
Segment by Type	Cardiac Catheterization Electrocardiogram (ECG) Chest X-Ray Stress Test Others
Segment by Application	Hospital & Clinics Ambulatory Surgical Centers Research Institutes
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Abbott Laboratories, B. Braun Melsungen AG, Boston Scientific Corp., Medtronic, CryoLife Inc., Edwards Lifesciences Corporation, LivaNova PLC, Neovasc Inc., Micro Interventional Devices, Symetis SA, Jenavalve Technology, TTK Healthcare Limited, Colibri Heart Valve, Lepu Medical Technology Co., Braile Biomédica
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Valvular Heart Disease Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Valvular Heart Disease Treatment Market report?

Ans: The main players in the Valvular Heart Disease Treatment Market are Abbott Laboratories, B. Braun Melsungen AG, Boston Scientific Corp., Medtronic, CryoLife Inc., Edwards Lifesciences Corporation, LivaNova PLC, Neovasc Inc., Micro Interventional Devices, Symetis SA, Jenavalve Technology, TTK Healthcare Limited, Colibri Heart Valve, Lepu Medical Technology Co., Braile Biomédica

What are the Application segmentation covered in the Valvular Heart Disease Treatment Market report?

Ans: The Applications covered in the Valvular Heart Disease Treatment Market report are Hospital & Clinics, Ambulatory Surgical Centers, Research Institutes

What are the Type segmentation covered in the Valvular Heart Disease Treatment Market report?

Ans: The Types covered in the Valvular Heart Disease Treatment Market report are Cardiac Catheterization, Electrocardiogram (ECG), Chest X-Ray, Stress Test, Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Valvular Heart Disease Treatment Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Cardiac Catheterization

1.2.3 Electrocardiogram (ECG)

1.2.4 Chest X-Ray

1.2.5 Stress Test

1.2.6 Others

1.3 Market by Application

1.3.1 Global Valvular Heart Disease Treatment Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Hospital & Clinics

1.3.3 Ambulatory Surgical Centers

1.3.4 Research Institutes

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Valvular Heart Disease Treatment Market Perspective (2019-2030)

2.2 Valvular Heart Disease Treatment Growth Trends by Region

2.2.1 Global Valvular Heart Disease Treatment Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Valvular Heart Disease Treatment Historic Market Size by Region (2019-2024)

2.2.3 Valvular Heart Disease Treatment Forecasted Market Size by Region (2025-2030)

2.3 Valvular Heart Disease Treatment Market Dynamics

2.3.1 Valvular Heart Disease Treatment Industry Trends

2.3.2 Valvular Heart Disease Treatment Market Drivers

2.3.3 Valvular Heart Disease Treatment Market Challenges

2.3.4 Valvular Heart Disease Treatment Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Valvular Heart Disease Treatment Players by Revenue

3.1.1 Global Top Valvular Heart Disease Treatment Players by Revenue (2019-2024)

3.1.2 Global Valvular Heart Disease Treatment Revenue Market Share by Players (2019-2024)

3.2 Global Valvular Heart Disease Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Valvular Heart Disease Treatment Revenue

3.4 Global Valvular Heart Disease Treatment Market Concentration Ratio

3.4.1 Global Valvular Heart Disease Treatment Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Valvular Heart Disease Treatment Revenue in 2023

3.5 Valvular Heart Disease Treatment Key Players Head office and Area Served

3.6 Key Players Valvular Heart Disease Treatment Product Solution and Service

3.7 Date of Enter into Valvular Heart Disease Treatment Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Valvular Heart Disease Treatment Breakdown Data by Type

4.1 Global Valvular Heart Disease Treatment Historic Market Size by Type (2019-2024)

4.2 Global Valvular Heart Disease Treatment Forecasted Market Size by Type (2025-2030)

5 Valvular Heart Disease Treatment Breakdown Data by Application

5.1 Global Valvular Heart Disease Treatment Historic Market Size by Application (2019-2024)

5.2 Global Valvular Heart Disease Treatment Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Valvular Heart Disease Treatment Market Size (2019-2030)

6.2 North America Valvular Heart Disease Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Valvular Heart Disease Treatment Market Size by Country (2019-2024)

6.4 North America Valvular Heart Disease Treatment Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Valvular Heart Disease Treatment Market Size (2019-2030)

7.2 Europe Valvular Heart Disease Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Valvular Heart Disease Treatment Market Size by Country (2019-2024)

7.4 Europe Valvular Heart Disease Treatment Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Valvular Heart Disease Treatment Market Size (2019-2030)

8.2 Asia-Pacific Valvular Heart Disease Treatment Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Valvular Heart Disease Treatment Market Size by Region (2019-2024)

8.4 Asia-Pacific Valvular Heart Disease Treatment Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Valvular Heart Disease Treatment Market Size (2019-2030)

9.2 Latin America Valvular Heart Disease Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Valvular Heart Disease Treatment Market Size by Country (2019-2024)

9.4 Latin America Valvular Heart Disease Treatment Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Valvular Heart Disease Treatment Market Size (2019-2030)

10.2 Middle East & Africa Valvular Heart Disease Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Valvular Heart Disease Treatment Market Size by Country (2019-2024)

10.4 Middle East & Africa Valvular Heart Disease Treatment Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Abbott Laboratories

11.1.1 Abbott Laboratories Company Detail

11.1.2 Abbott Laboratories Business Overview

11.1.3 Abbott Laboratories Valvular Heart Disease Treatment Introduction

11.1.4 Abbott Laboratories Revenue in Valvular Heart Disease Treatment Business (2019-2024)

11.1.5 Abbott Laboratories Recent Development

11.2 B. Braun Melsungen AG

11.2.1 B. Braun Melsungen AG Company Detail

11.2.2 B. Braun Melsungen AG Business Overview

11.2.3 B. Braun Melsungen AG Valvular Heart Disease Treatment Introduction

11.2.4 B. Braun Melsungen AG Revenue in Valvular Heart Disease Treatment Business (2019-2024)

11.2.5 B. Braun Melsungen AG Recent Development

11.3 Boston Scientific Corp.

11.3.1 Boston Scientific Corp. Company Detail

11.3.2 Boston Scientific Corp. Business Overview

11.3.3 Boston Scientific Corp. Valvular Heart Disease Treatment Introduction

11.3.4 Boston Scientific Corp. Revenue in Valvular Heart Disease Treatment Business (2019-2024)

11.3.5 Boston Scientific Corp. Recent Development

11.4 Medtronic

11.4.1 Medtronic Company Detail

11.4.2 Medtronic Business Overview

11.4.3 Medtronic Valvular Heart Disease Treatment Introduction

11.4.4 Medtronic Revenue in Valvular Heart Disease Treatment Business (2019-2024)

11.4.5 Medtronic Recent Development

11.5 CryoLife Inc.

11.5.1 CryoLife Inc. Company Detail

11.5.2 CryoLife Inc. Business Overview

11.5.3 CryoLife Inc. Valvular Heart Disease Treatment Introduction

11.5.4 CryoLife Inc. Revenue in Valvular Heart Disease Treatment Business (2019-2024)

11.5.5 CryoLife Inc. Recent Development

11.6 Edwards Lifesciences Corporation

11.6.1 Edwards Lifesciences Corporation Company Detail

11.6.2 Edwards Lifesciences Corporation Business Overview

11.6.3 Edwards Lifesciences Corporation Valvular Heart Disease Treatment Introduction

11.6.4 Edwards Lifesciences Corporation Revenue in Valvular Heart Disease Treatment Business (2019-2024)

11.6.5 Edwards Lifesciences Corporation Recent Development

11.7 LivaNova PLC

11.7.1 LivaNova PLC Company Detail

11.7.2 LivaNova PLC Business Overview

11.7.3 LivaNova PLC Valvular Heart Disease Treatment Introduction

11.7.4 LivaNova PLC Revenue in Valvular Heart Disease Treatment Business (2019-2024)

11.7.5 LivaNova PLC Recent Development

11.8 Neovasc Inc.

11.8.1 Neovasc Inc. Company Detail

11.8.2 Neovasc Inc. Business Overview

11.8.3 Neovasc Inc. Valvular Heart Disease Treatment Introduction

11.8.4 Neovasc Inc. Revenue in Valvular Heart Disease Treatment Business (2019-2024)

11.8.5 Neovasc Inc. Recent Development

11.9 Micro Interventional Devices

11.9.1 Micro Interventional Devices Company Detail

11.9.2 Micro Interventional Devices Business Overview

11.9.3 Micro Interventional Devices Valvular Heart Disease Treatment Introduction

11.9.4 Micro Interventional Devices Revenue in Valvular Heart Disease Treatment Business (2019-2024)

11.9.5 Micro Interventional Devices Recent Development

11.10 Symetis SA

11.10.1 Symetis SA Company Detail

11.10.2 Symetis SA Business Overview

11.10.3 Symetis SA Valvular Heart Disease Treatment Introduction

11.10.4 Symetis SA Revenue in Valvular Heart Disease Treatment Business (2019-2024)

11.10.5 Symetis SA Recent Development

11.11 Jenavalve Technology

11.11.1 Jenavalve Technology Company Detail

11.11.2 Jenavalve Technology Business Overview

11.11.3 Jenavalve Technology Valvular Heart Disease Treatment Introduction

11.11.4 Jenavalve Technology Revenue in Valvular Heart Disease Treatment Business (2019-2024)

11.11.5 Jenavalve Technology Recent Development

11.12 TTK Healthcare Limited

11.12.1 TTK Healthcare Limited Company Detail

11.12.2 TTK Healthcare Limited Business Overview

11.12.3 TTK Healthcare Limited Valvular Heart Disease Treatment Introduction

11.12.4 TTK Healthcare Limited Revenue in Valvular Heart Disease Treatment Business (2019-2024)

11.12.5 TTK Healthcare Limited Recent Development

11.13 Colibri Heart Valve

11.13.1 Colibri Heart Valve Company Detail

11.13.2 Colibri Heart Valve Business Overview

11.13.3 Colibri Heart Valve Valvular Heart Disease Treatment Introduction

11.13.4 Colibri Heart Valve Revenue in Valvular Heart Disease Treatment Business (2019-2024)

11.13.5 Colibri Heart Valve Recent Development

11.14 Lepu Medical Technology Co.

11.14.1 Lepu Medical Technology Co. Company Detail

11.14.2 Lepu Medical Technology Co. Business Overview

11.14.3 Lepu Medical Technology Co. Valvular Heart Disease Treatment Introduction

11.14.4 Lepu Medical Technology Co. Revenue in Valvular Heart Disease Treatment Business (2019-2024)

11.14.5 Lepu Medical Technology Co. Recent Development

11.15 Braile Biomédica

11.15.1 Braile Biomédica Company Detail

11.15.2 Braile Biomédica Business Overview

11.15.3 Braile Biomédica Valvular Heart Disease Treatment Introduction

11.15.4 Braile Biomédica Revenue in Valvular Heart Disease Treatment Business (2019-2024)

11.15.5 Braile Biomédica Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Abbott Laboratories

B Braun Melsungen AG

Boston Scientific Corp

Medtronic Inc

CryoLife

Edwards Lifesciences Corporation

LivaNova

Neovasc Inc

Micro Interventional Devices

Symetis SA

Jenavalve Technology

TTK Healthcare Limited

Colibri Heart Valve

Lepu Medical Technology Co.

Braile Biomédica

List of Tables

Table 1. Global Valvular Heart Disease Treatment Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Cardiac Catheterization

Table 3. Key Players of Electrocardiogram (ECG)

Table 4. Key Players of Chest X-Ray

Table 5. Key Players of Stress Test

Table 6. Key Players of Others

Table 7. Global Valvular Heart Disease Treatment Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 8. Global Valvular Heart Disease Treatment Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 9. Global Valvular Heart Disease Treatment Market Size by Region (2019-2024) & (US$ Million)

Table 10. Global Valvular Heart Disease Treatment Market Share by Region (2019-2024)

Table 11. Global Valvular Heart Disease Treatment Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 12. Global Valvular Heart Disease Treatment Market Share by Region (2025-2030)

Table 13. Valvular Heart Disease Treatment Market Trends

Table 14. Valvular Heart Disease Treatment Market Drivers

Table 15. Valvular Heart Disease Treatment Market Challenges

Table 16. Valvular Heart Disease Treatment Market Restraints

Table 17. Global Valvular Heart Disease Treatment Revenue by Players (2019-2024) & (US$ Million)

Table 18. Global Valvular Heart Disease Treatment Market Share by Players (2019-2024)

Table 19. Global Top Valvular Heart Disease Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Valvular Heart Disease Treatment as of 2023)

Table 20. Ranking of Global Top Valvular Heart Disease Treatment Companies by Revenue (US$ Million) in 2023

Table 21. Global 5 Largest Players Market Share by Valvular Heart Disease Treatment Revenue (CR5 and HHI) & (2019-2024)

Table 22. Key Players Headquarters and Area Served

Table 23. Key Players Valvular Heart Disease Treatment Product Solution and Service

Table 24. Date of Enter into Valvular Heart Disease Treatment Market

Table 25. Mergers & Acquisitions, Expansion Plans

Table 26. Global Valvular Heart Disease Treatment Market Size by Type (2019-2024) & (US$ Million)

Table 27. Global Valvular Heart Disease Treatment Revenue Market Share by Type (2019-2024)

Table 28. Global Valvular Heart Disease Treatment Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 29. Global Valvular Heart Disease Treatment Revenue Market Share by Type (2025-2030)

Table 30. Global Valvular Heart Disease Treatment Market Size by Application (2019-2024) & (US$ Million)

Table 31. Global Valvular Heart Disease Treatment Revenue Market Share by Application (2019-2024)

Table 32. Global Valvular Heart Disease Treatment Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 33. Global Valvular Heart Disease Treatment Revenue Market Share by Application (2025-2030)

Table 34. North America Valvular Heart Disease Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 35. North America Valvular Heart Disease Treatment Market Size by Country (2019-2024) & (US$ Million)

Table 36. North America Valvular Heart Disease Treatment Market Size by Country (2025-2030) & (US$ Million)

Table 37. Europe Valvular Heart Disease Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 38. Europe Valvular Heart Disease Treatment Market Size by Country (2019-2024) & (US$ Million)

Table 39. Europe Valvular Heart Disease Treatment Market Size by Country (2025-2030) & (US$ Million)

Table 40. Asia-Pacific Valvular Heart Disease Treatment Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 41. Asia-Pacific Valvular Heart Disease Treatment Market Size by Region (2019-2024) & (US$ Million)

Table 42. Asia-Pacific Valvular Heart Disease Treatment Market Size by Region (2025-2030) & (US$ Million)

Table 43. Latin America Valvular Heart Disease Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 44. Latin America Valvular Heart Disease Treatment Market Size by Country (2019-2024) & (US$ Million)

Table 45. Latin America Valvular Heart Disease Treatment Market Size by Country (2025-2030) & (US$ Million)

Table 46. Middle East & Africa Valvular Heart Disease Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 47. Middle East & Africa Valvular Heart Disease Treatment Market Size by Country (2019-2024) & (US$ Million)

Table 48. Middle East & Africa Valvular Heart Disease Treatment Market Size by Country (2025-2030) & (US$ Million)

Table 49. Abbott Laboratories Company Detail

Table 50. Abbott Laboratories Business Overview

Table 51. Abbott Laboratories Valvular Heart Disease Treatment Product

Table 52. Abbott Laboratories Revenue in Valvular Heart Disease Treatment Business (2019-2024) & (US$ Million)

Table 53. Abbott Laboratories Recent Development

Table 54. B. Braun Melsungen AG Company Detail

Table 55. B. Braun Melsungen AG Business Overview

Table 56. B. Braun Melsungen AG Valvular Heart Disease Treatment Product

Table 57. B. Braun Melsungen AG Revenue in Valvular Heart Disease Treatment Business (2019-2024) & (US$ Million)

Table 58. B. Braun Melsungen AG Recent Development

Table 59. Boston Scientific Corp. Company Detail

Table 60. Boston Scientific Corp. Business Overview

Table 61. Boston Scientific Corp. Valvular Heart Disease Treatment Product

Table 62. Boston Scientific Corp. Revenue in Valvular Heart Disease Treatment Business (2019-2024) & (US$ Million)

Table 63. Boston Scientific Corp. Recent Development

Table 64. Medtronic Company Detail

Table 65. Medtronic Business Overview

Table 66. Medtronic Valvular Heart Disease Treatment Product

Table 67. Medtronic Revenue in Valvular Heart Disease Treatment Business (2019-2024) & (US$ Million)

Table 68. Medtronic Recent Development

Table 69. CryoLife Inc. Company Detail

Table 70. CryoLife Inc. Business Overview

Table 71. CryoLife Inc. Valvular Heart Disease Treatment Product

Table 72. CryoLife Inc. Revenue in Valvular Heart Disease Treatment Business (2019-2024) & (US$ Million)

Table 73. CryoLife Inc. Recent Development

Table 74. Edwards Lifesciences Corporation Company Detail

Table 75. Edwards Lifesciences Corporation Business Overview

Table 76. Edwards Lifesciences Corporation Valvular Heart Disease Treatment Product

Table 77. Edwards Lifesciences Corporation Revenue in Valvular Heart Disease Treatment Business (2019-2024) & (US$ Million)

Table 78. Edwards Lifesciences Corporation Recent Development

Table 79. LivaNova PLC Company Detail

Table 80. LivaNova PLC Business Overview

Table 81. LivaNova PLC Valvular Heart Disease Treatment Product

Table 82. LivaNova PLC Revenue in Valvular Heart Disease Treatment Business (2019-2024) & (US$ Million)

Table 83. LivaNova PLC Recent Development

Table 84. Neovasc Inc. Company Detail

Table 85. Neovasc Inc. Business Overview

Table 86. Neovasc Inc. Valvular Heart Disease Treatment Product

Table 87. Neovasc Inc. Revenue in Valvular Heart Disease Treatment Business (2019-2024) & (US$ Million)

Table 88. Neovasc Inc. Recent Development

Table 89. Micro Interventional Devices Company Detail

Table 90. Micro Interventional Devices Business Overview

Table 91. Micro Interventional Devices Valvular Heart Disease Treatment Product

Table 92. Micro Interventional Devices Revenue in Valvular Heart Disease Treatment Business (2019-2024) & (US$ Million)

Table 93. Micro Interventional Devices Recent Development

Table 94. Symetis SA Company Detail

Table 95. Symetis SA Business Overview

Table 96. Symetis SA Valvular Heart Disease Treatment Product

Table 97. Symetis SA Revenue in Valvular Heart Disease Treatment Business (2019-2024) & (US$ Million)

Table 98. Symetis SA Recent Development

Table 99. Jenavalve Technology Company Detail

Table 100. Jenavalve Technology Business Overview

Table 101. Jenavalve Technology Valvular Heart Disease Treatment Product

Table 102. Jenavalve Technology Revenue in Valvular Heart Disease Treatment Business (2019-2024) & (US$ Million)

Table 103. Jenavalve Technology Recent Development

Table 104. TTK Healthcare Limited Company Detail

Table 105. TTK Healthcare Limited Business Overview

Table 106. TTK Healthcare Limited Valvular Heart Disease Treatment Product

Table 107. TTK Healthcare Limited Revenue in Valvular Heart Disease Treatment Business (2019-2024) & (US$ Million)

Table 108. TTK Healthcare Limited Recent Development

Table 109. Colibri Heart Valve Company Detail

Table 110. Colibri Heart Valve Business Overview

Table 111. Colibri Heart Valve Valvular Heart Disease Treatment Product

Table 112. Colibri Heart Valve Revenue in Valvular Heart Disease Treatment Business (2019-2024) & (US$ Million)

Table 113. Colibri Heart Valve Recent Development

Table 114. Lepu Medical Technology Co. Company Detail

Table 115. Lepu Medical Technology Co. Business Overview

Table 116. Lepu Medical Technology Co. Valvular Heart Disease Treatment Product

Table 117. Lepu Medical Technology Co. Revenue in Valvular Heart Disease Treatment Business (2019-2024) & (US$ Million)

Table 118. Lepu Medical Technology Co. Recent Development

Table 119. Braile Biomédica Company Detail

Table 120. Braile Biomédica Business Overview

Table 121. Braile Biomédica Valvular Heart Disease Treatment Product

Table 122. Braile Biomédica Revenue in Valvular Heart Disease Treatment Business (2019-2024) & (US$ Million)

Table 123. Braile Biomédica Recent Development

Table 124. Research Programs/Design for This Report

Table 125. Key Data Information from Secondary Sources

Table 126. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Valvular Heart Disease Treatment Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global Valvular Heart Disease Treatment Market Share by Type: 2023 VS 2030

Figure 3. Cardiac Catheterization Features

Figure 4. Electrocardiogram (ECG) Features

Figure 5. Chest X-Ray Features

Figure 6. Stress Test Features

Figure 7. Others Features

Figure 8. Global Valvular Heart Disease Treatment Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 9. Global Valvular Heart Disease Treatment Market Share by Application: 2023 VS 2030

Figure 10. Hospital & Clinics Case Studies

Figure 11. Ambulatory Surgical Centers Case Studies

Figure 12. Research Institutes Case Studies

Figure 13. Valvular Heart Disease Treatment Report Years Considered

Figure 14. Global Valvular Heart Disease Treatment Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 15. Global Valvular Heart Disease Treatment Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 16. Global Valvular Heart Disease Treatment Market Share by Region: 2023 VS 2030

Figure 17. Global Valvular Heart Disease Treatment Market Share by Players in 2023

Figure 18. Global Top Valvular Heart Disease Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Valvular Heart Disease Treatment as of 2023)

Figure 19. The Top 10 and 5 Players Market Share by Valvular Heart Disease Treatment Revenue in 2023

Figure 20. North America Valvular Heart Disease Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 21. North America Valvular Heart Disease Treatment Market Share by Country (2019-2030)

Figure 22. United States Valvular Heart Disease Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. Canada Valvular Heart Disease Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. Europe Valvular Heart Disease Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. Europe Valvular Heart Disease Treatment Market Share by Country (2019-2030)

Figure 26. Germany Valvular Heart Disease Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. France Valvular Heart Disease Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. U.K. Valvular Heart Disease Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Italy Valvular Heart Disease Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Russia Valvular Heart Disease Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Nordic Countries Valvular Heart Disease Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Asia-Pacific Valvular Heart Disease Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Asia-Pacific Valvular Heart Disease Treatment Market Share by Region (2019-2030)

Figure 34. China Valvular Heart Disease Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. Japan Valvular Heart Disease Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. South Korea Valvular Heart Disease Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. Southeast Asia Valvular Heart Disease Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. India Valvular Heart Disease Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. Australia Valvular Heart Disease Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. Latin America Valvular Heart Disease Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. Latin America Valvular Heart Disease Treatment Market Share by Country (2019-2030)

Figure 42. Mexico Valvular Heart Disease Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Brazil Valvular Heart Disease Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Middle East & Africa Valvular Heart Disease Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Middle East & Africa Valvular Heart Disease Treatment Market Share by Country (2019-2030)

Figure 46. Turkey Valvular Heart Disease Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. Saudi Arabia Valvular Heart Disease Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 48. Abbott Laboratories Revenue Growth Rate in Valvular Heart Disease Treatment Business (2019-2024)

Figure 49. B. Braun Melsungen AG Revenue Growth Rate in Valvular Heart Disease Treatment Business (2019-2024)

Figure 50. Boston Scientific Corp. Revenue Growth Rate in Valvular Heart Disease Treatment Business (2019-2024)

Figure 51. Medtronic Revenue Growth Rate in Valvular Heart Disease Treatment Business (2019-2024)

Figure 52. CryoLife Inc. Revenue Growth Rate in Valvular Heart Disease Treatment Business (2019-2024)

Figure 53. Edwards Lifesciences Corporation Revenue Growth Rate in Valvular Heart Disease Treatment Business (2019-2024)

Figure 54. LivaNova PLC Revenue Growth Rate in Valvular Heart Disease Treatment Business (2019-2024)

Figure 55. Neovasc Inc. Revenue Growth Rate in Valvular Heart Disease Treatment Business (2019-2024)

Figure 56. Micro Interventional Devices Revenue Growth Rate in Valvular Heart Disease Treatment Business (2019-2024)

Figure 57. Symetis SA Revenue Growth Rate in Valvular Heart Disease Treatment Business (2019-2024)

Figure 58. Jenavalve Technology Revenue Growth Rate in Valvular Heart Disease Treatment Business (2019-2024)

Figure 59. TTK Healthcare Limited Revenue Growth Rate in Valvular Heart Disease Treatment Business (2019-2024)

Figure 60. Colibri Heart Valve Revenue Growth Rate in Valvular Heart Disease Treatment Business (2019-2024)

Figure 61. Lepu Medical Technology Co. Revenue Growth Rate in Valvular Heart Disease Treatment Business (2019-2024)

Figure 62. Braile Biomédica Revenue Growth Rate in Valvular Heart Disease Treatment Business (2019-2024)

Figure 63. Bottom-up and Top-down Approaches for This Report

Figure 64. Data Triangulation

Figure 65. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Therapeutic Medical Stent Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-8T15352

Fri Oct 04 00:00:00 UTC 2024

Add to Cart

Global Vascular Embolization Agent Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-2D13682

Fri Oct 04 00:00:00 UTC 2024

Add to Cart

Global Extravascular Implantable Cardioverter Defibrillator System Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-31M15462

Thu Oct 03 00:00:00 UTC 2024

Add to Cart

Global Transcatheter Mitral Valve Clip System Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-38C15386

Thu Oct 03 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions